Abstract
The status of adipose tissue changes rapidly. From a simple filler tissue, it successively acquires the status of metabolic active tissue, endocrine tissue, plastic tissue, and finally that of a large reservoir of cells suitable for cell therapy and regenerative medicine. All throughout this story, our knowledge has been largely dependent on genetic tools and gene transfer. Now, the time has come where gene transfer in adipose derived cells can be envisioned, not only for understanding the role or importance of one gene, but also to engineer adipose derived cells for the purpose of therapy by delivering secreted products. In this paper, after a brief overview of adipose tissues, a large part will be devoted to the use of virusbased gene transfer in transducing adipose tissue and cells which reside therein. We also critically review the use of adipose “specific” promoters and the applications already described in the literature.
Keywords: Adipose tissue, preadipocytes, adipose derived cells, virus, promoter, shRNA, cell therapy
Current Gene Therapy
Title: Virus-based Gene Transfer Approaches and Adipose Tissue Biology
Volume: 8 Issue: 2
Author(s): Louis Casteilla, Beatrice Cousin, Valerie Planat-Benard, Patrick Laharrague, Mamen Carmona and Luc Penicaud
Affiliation:
Keywords: Adipose tissue, preadipocytes, adipose derived cells, virus, promoter, shRNA, cell therapy
Abstract: The status of adipose tissue changes rapidly. From a simple filler tissue, it successively acquires the status of metabolic active tissue, endocrine tissue, plastic tissue, and finally that of a large reservoir of cells suitable for cell therapy and regenerative medicine. All throughout this story, our knowledge has been largely dependent on genetic tools and gene transfer. Now, the time has come where gene transfer in adipose derived cells can be envisioned, not only for understanding the role or importance of one gene, but also to engineer adipose derived cells for the purpose of therapy by delivering secreted products. In this paper, after a brief overview of adipose tissues, a large part will be devoted to the use of virusbased gene transfer in transducing adipose tissue and cells which reside therein. We also critically review the use of adipose “specific” promoters and the applications already described in the literature.
Export Options
About this article
Cite this article as:
Casteilla Louis, Cousin Beatrice, Planat-Benard Valerie, Laharrague Patrick, Carmona Mamen and Penicaud Luc, Virus-based Gene Transfer Approaches and Adipose Tissue Biology, Current Gene Therapy 2008; 8 (2) . https://dx.doi.org/10.2174/156652308784049354
DOI https://dx.doi.org/10.2174/156652308784049354 |
Print ISSN 1566-5232 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5631 |
Call for Papers in Thematic Issues
Programmed Cell Death Genes in Oncology: Pioneering Therapeutic and Diagnostic Frontiers (BMS-CGT-2024-HT-45)
Programmed Cell Death (PCD) is recognized as a pivotal biological mechanism with far-reaching effects in the realm of cancer therapy. This complex process encompasses a variety of cell death modalities, including apoptosis, autophagic cell death, pyroptosis, and ferroptosis, each of which contributes to the intricate landscape of cancer development and ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Inhibitory Smad7: Emerging Roles in Health and Disease
Current Molecular Pharmacology Stem Cells as Delivery Vehicles for Oncolytic Adenoviral Virotherapy
Current Gene Therapy Targeting DNA G-Quadruplex Structures with Peptide Nucleic Acids
Current Pharmaceutical Design Repositioning the Old Fungicide Ciclopirox for New Medical Uses
Current Pharmaceutical Design The Role of Cellular Plasticity in Cancer Development
Current Medicinal Chemistry Abrogation of the G2 Checkpoint by Inhibition of Wee-1 Kinase Results in Sensitization of p53-Deficient Tumor Cells to DNA-Damaging Agents
Current Clinical Pharmacology Adrenoceptors: Non Conventional Target for Breast Cancer?
Current Medicinal Chemistry Feud or Friend? The Role of the miR-17-92 Cluster in Tumorigenesis
Current Genomics Perspectives in Cell Cycle Regulation: Lessons from an Anoxic Vertebrate
Current Genomics Cell Cycle Regulatory Kinase Modulators: Interim Progress and Issues
Current Topics in Medicinal Chemistry A Dual Role of Cyclin E in Cell Proliferation and Apotosis May Provide a Target for Cancer Therapy
Current Cancer Drug Targets Epigenetic and Disease Targets by Polyphenols
Current Pharmaceutical Design Small Interfering RNA for Effective Cancer Therapies
Mini-Reviews in Medicinal Chemistry Mouse Models of Primary Sjogren’s Syndrome
Current Pharmaceutical Design Overcoming Antibiotic Resistance: Insights from Clostridium difficile and the RB Tumor Suppressor
Protein & Peptide Letters Targeted Therapies in Solid Tumours: Pinpointing the Tumours Achilles Heel
Current Pharmaceutical Design Inhibitor at the Gates, Inhibitor in the Chamber: Allosteric and Competitive Inhibitors of the Proteasome as Prospective Drugs
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents The Effect of Claudin-5 Overexpression on the Interactions of Claudin-1 and -2 and Barrier Function in Retinal Cells
Current Molecular Medicine Interactions Between Cholinergic and Fibroblast Growth Factor Receptors in Brain Trophism and Plasticity
Current Protein & Peptide Science New Ways to Improve Breast Cancer Therapy Targeting Specific Molecular Pathways
Current Cancer Therapy Reviews